Sandra-Annika Quast

General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC

Sandra-Annika Quast, Anja Berger, Nicole Buttstädt et al. · PLoS ONE · 2012 · 64 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative—Enhancement of both extrinsic and intrinsic apoptosis pathways

Anja Berger, Sandra-Annika Quast, Michael Plötz et al. · Biochemical Pharmacology · 2010 · 46 citations

Life Sciences, Oncology, Pharmacology +17

RAF Inhibition Overcomes Resistance to TRAIL-Induced Apoptosis in Melanoma Cells

Anja Berger, Sandra-Annika Quast, Michael Plötz et al. · Journal of Investigative Dermatology · 2013 · 37 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

The BH3-only protein BimL overrides Bcl-2-mediated apoptosis resistance in melanoma cells

Michael Plötz, Bernhard Gillissen, Sandra-Annika Quast et al. · Cancer Letters · 2013 · 17 citations

Life Sciences, Cell Biology, Molecular Biology +14

Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins

Sandra-Annika Quast, Katja Steinhorst, Michael Plötz et al. · Journal of Investigative Dermatology · 2015 · 17 citations · Full text

Life Sciences, Cell Biology, Oncology +17